ASCO® GI 2025 Summary: Evaluating the Clinical Benefits of Anti-Cancer Drugs Approved by FDA for GI Neoplasms for the Past Two Decades | VuMedi

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

10 seconds

Playback speed

This video is featured in the Insights from 2025 ASCO® GI Annual Meeting

Insights from 2025 ASCO® GI Annual Meeting

ASCO® GI 2025 Summary: Evaluating the Clinical Benefits of Anti-Cancer Drugs Approved by FDA for GI Neoplasms for the Past Two Decades

By Insights from 2025 ASCO® GI Annual Meeting FEATURING Fares Jamal

By Insights from 2025 ASCO® GI Annual Meeting FEATURING Fares Jamal

120 views

February 10, 2025

Comments 0

Login to view comments. Click here to Login